Group One Trading’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Group One Trading’s Portfolio SRRA Stock Details SRRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-212	Closed	-$6.08K	–	9079
2021 Q4	$5K	Hold	212	–	–	﹤0.01%	7677
2021 Q3	$5K	Hold	212	–	–	﹤0.01%	7785
2021 Q2	$4K	Hold	212	–	–	﹤0.01%	7851
2021 Q1	$4K	Hold	212	–	–	﹤0.01%	7317
2020 Q4	$3K	Hold	212	–	–	﹤0.01%	6208
2020 Q3	$2K	Hold	212	–	–	﹤0.01%	5872
2020 Q2	$3K	Hold	212	–	–	﹤0.01%	5521
2020 Q1	$2K	Sell	212 -1	-0.5%	-$13	﹤0.01%	5028
2019 Q4	$3K	Buy	+213	New	+$2.78K	﹤0.01%	4865
2018 Q3	–	Sell	-250	Closed	-$30K	–	5788
2018 Q2	$30K	Hold	250	–	–	﹤0.01%	4215
2018 Q1	$21K	Buy	+250	New	+$28.3K	﹤0.01%	4076

Other funds holding SRRA

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Group One Trading's SRRA Position: Q1 2022 in Review

Group One Trading sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q1 2022, closing a stake of 212 shares — an estimated $6.08K sold.

Group One Trading first reported a position in SRRA in Q1 2018 and held it in 11 quarters. The position peaked at $30K in Q2 2018. 75 funds tracked by Wall St. Rank hold SRRA as of Q1 2022.

Group One Trading reported no remaining Sierra Oncology, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
Group One Trading sold 212 Sierra Oncology, Inc. Common Stock shares in Q1 2022, an estimated $6.08K.
Group One Trading first reported a position in Sierra Oncology, Inc. Common Stock in Q1 2018 and held it in 11 quarters.
Group One Trading's Sierra Oncology, Inc. Common Stock position peaked at $30K in Q2 2018.
75 funds tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q1 2022.

Based on Group One Trading's 13F filing for Q1 2022, filed 12 May 2022.